KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Jun 26, 2025 >>  ABB India 6015.2  [ 0.81% ]  ACC 1881.3  [ 1.45% ]  Ambuja Cements 566.65  [ 1.29% ]  Asian Paints Ltd. 2289.2  [ 0.43% ]  Axis Bank Ltd. 1234.35  [ 1.78% ]  Bajaj Auto 8432.6  [ 0.53% ]  Bank of Baroda 239.3  [ 0.06% ]  Bharti Airtel 2014.2  [ 2.48% ]  Bharat Heavy Ele 264.6  [ 1.05% ]  Bharat Petroleum 329.6  [ 3.16% ]  Britannia Ind. 5828.8  [ 2.15% ]  Cipla 1512.75  [ 0.18% ]  Coal India 394.05  [ 0.60% ]  Colgate Palm. 2376.1  [ -1.81% ]  Dabur India 481.75  [ 0.34% ]  DLF Ltd. 847.2  [ -0.84% ]  Dr. Reddy's Labs 1321.2  [ -1.47% ]  GAIL (India) 186.85  [ 1.58% ]  Grasim Inds. 2876.9  [ 1.63% ]  HCL Technologies 1723.7  [ 0.41% ]  HDFC Bank 2023  [ 2.16% ]  Hero MotoCorp 4279.85  [ -0.48% ]  Hindustan Unilever L 2280.2  [ 0.09% ]  Hindalco Indus. 690.55  [ 2.70% ]  ICICI Bank 1439.25  [ 0.94% ]  Indian Hotels Co 783.5  [ 0.22% ]  IndusInd Bank 835.9  [ 0.75% ]  Infosys L 1615  [ -0.03% ]  ITC Ltd. 420.35  [ 0.96% ]  Jindal St & Pwr 954.65  [ 3.60% ]  Kotak Mahindra Bank 2204  [ 0.27% ]  L&T 3660.6  [ 1.17% ]  Lupin Ltd. 1926.1  [ -0.47% ]  Mahi. & Mahi 3215.4  [ 0.00% ]  Maruti Suzuki India 12716.45  [ -0.39% ]  MTNL 53.2  [ -0.02% ]  Nestle India 2429.8  [ 1.05% ]  NIIT Ltd. 131.45  [ -0.04% ]  NMDC Ltd. 70.55  [ 2.20% ]  NTPC 337.15  [ 1.92% ]  ONGC 244.55  [ 1.05% ]  Punj. NationlBak 106.25  [ 0.28% ]  Power Grid Corpo 293.4  [ 1.02% ]  Reliance Inds. 1495.2  [ 1.90% ]  SBI 797  [ -0.39% ]  Vedanta 455.55  [ 3.04% ]  Shipping Corpn. 222.15  [ -0.72% ]  Sun Pharma. 1669.3  [ -0.07% ]  Tata Chemicals 935.05  [ -0.64% ]  Tata Consumer Produc 1144.2  [ 1.59% ]  Tata Motors 683  [ 1.28% ]  Tata Steel 160.5  [ 2.62% ]  Tata Power Co. 405.5  [ 0.62% ]  Tata Consultancy 3441.65  [ -0.12% ]  Tech Mahindra 1690.9  [ -0.79% ]  UltraTech Cement 11944.8  [ 1.80% ]  United Spirits 1446.85  [ -0.56% ]  Wipro 268.35  [ -0.39% ]  Zee Entertainment En 143.75  [ -1.74% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

AAREY DRUGS & PHARMACEUTICALS LTD.

26 June 2025 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE198H01019 BSE Code / NSE Code 524412 / AAREYDRUGS Book Value (Rs.) 46.93 Face Value 10.00
Bookclosure 30/09/2024 52Week High 75 EPS 1.42 P/E 45.63
Market Cap. 183.59 Cr. 52Week Low 31 P/BV / Div Yield (%) 1.38 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Aarey Drugs & Pharmaceuticals Ltd. (ADPL) was originally incorporated as a private limited company in the name of Niharika Textiles & Chemicals Pvt. Ltd. on 15th May 1990. The Aarey group of companie belonging to the Ghatalia group of companies took over the company and converted it into a public limited company on 18th march 1993. Its name was since changed to Aarey Drugs & Pharmaceuticals Ltd.

The main object of the company is to set up facilities for manufacture of bulk drugs. As an immediate step the company has undertaken a project to manufacture Metronidazole and Metronidazole Benzoate at its works situated at E-34, MIDC Estate.

2008

-Aarey Drugs & Pharmaceuticals Ltd has appointed Mr. Chetan Kiritbhai Mehta as an Independent Director of the Company from June 02, 2008.

2012

-Aarey Drugs & Pharmaceuticals Ltd Issues Rights in the Ratio of 2:1

-Aarey Drugs & Pharmaceuticals has given the Bonus in the Ratio of 1:5

2017 -The company has commenced production of new line of product Mefanamic Acid and has confirmed order for the same from its customers up till October, 2017.